RIZATRIPTAN TW rizatriptan (as benzoate) 5 mg orally disintegrating tablets blisters

Country: Ավստրալիա

language: անգլերեն

source: Department of Health (Therapeutic Goods Administration)

active_ingredient:

rizatriptan benzoate, Quantity: 7.265 mg (Equivalent: rizatriptan, Qty 5 mg)

MAH:

Arrotex Pharmaceuticals Pty Ltd

INN:

rizatriptan benzoate

pharmaceutical_form:

Tablet, orally disintegrating

composition:

Excipient Ingredients: mannitol; crospovidone; sodium stearylfumarate; ethylcellulose; colloidal anhydrous silica; silicon dioxide; hypromellose; acesulfame potassium; Flavour

administration_route:

Sublingual

units_in_package:

3, 2, 6

prescription_type:

(S4) Prescription Only Medicine

therapeutic_indication:

for acute treatment of migraine attacks with or without aura.

leaflet_short:

Visual Identification: White to off-white, round, flat face beveled edge tablets, debossed with 'C6' on one side and 'C' on the other side, having a characteristic flavour; Container Type: Blister Pack; Container Material: Other composite material; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Child resistant closure

authorization_status:

Licence status A

authorization_date:

2015-03-20